Clinical Trials Browser

Phase 1/2 × Sunitinib × Sarcoma × Clear all

NCT02401815 2025-02-14

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

Phase 1/2 Completed

51 enrolled 32 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03277924 2024-08-13

ImmunoSarc

Phase 1/2 Completed

197 enrolled

Sarcoma

Chondrosarcoma, Extraskeletal Myxoid, Bone Neoplasms, Chondrosarcoma, Hemangioendothelioma, Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Hemangioendothelioma, Epithelioid, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

NCT00753727 2011-06-23

SUNXRT

Phase 1/2 Unknown

26 enrolled

Sarcoma

NCT00457743 2009-11-13

A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Completed

36 enrolled 31 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors